ID

35962

Description

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction; ODM derived from: https://clinicaltrials.gov/show/NCT01920711

Link

https://clinicaltrials.gov/show/NCT01920711

Keywords

  1. 4/6/19 4/6/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 6, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Heart Failure With Preserved Ejection Fraction NCT01920711

Eligibility Heart Failure With Preserved Ejection Fraction NCT01920711

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
left ventricular ejection fraction (lvef) ≥45% prior to study entry.
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
symptom(s) of heart failure (hf) and requiring treatment with diuretic(s) for hf ≥30 days prior to study entry
Description

Symptoms Heart failure | Requirement Diuretics Heart failure

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0018801
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0012798
UMLS CUI [2,3]
C0018801
current symptom(s) of hf
Description

Symptoms Heart failure

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0018801
structural heart disease (left atrial enlargement or left ventricular hypertrophy) documented by echocardiogram
Description

Structural disorder of heart Echocardiography | Left atrial hypertrophy Echocardiography | Left Ventricular Hypertrophy Echocardiography

Data type

boolean

Alias
UMLS CUI [1,1]
C1290384
UMLS CUI [1,2]
C0013516
UMLS CUI [2,1]
C0238705
UMLS CUI [2,2]
C0013516
UMLS CUI [3,1]
C0149721
UMLS CUI [3,2]
C0013516
at least one of the following: a hf hospitalization within 9 months prior to study entry and/or an elevated nt-probnp.
Description

Hospitalization Due to Heart Failure | NT-proBNP increased

Data type

boolean

Alias
UMLS CUI [1]
C3898876
UMLS CUI [2]
C3203735
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any prior measurement of lvef < 45%.
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
acute coronary syndrome (including mi), cardiac surgery, other major cv surgery within 3 months , or urgent percutaneous coronary intervention (pci) within 30 days of entry.
Description

Acute Coronary Syndrome | Myocardial Infarction | Cardiac Surgery procedures | Cardiovascular Surgical Procedures Major | Percutaneous Coronary Intervention Urgent

Data type

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0018821
UMLS CUI [4,1]
C0038897
UMLS CUI [4,2]
C0205164
UMLS CUI [5,1]
C1532338
UMLS CUI [5,2]
C0439609
patients who have had an mi, coronary artery bypass graft (cabg) or other event within the 6 months prior to entry unless an echo measurement performed after the event confirms a lvef ≥45%.
Description

Myocardial Infarction | Coronary Artery Bypass Surgery | Event | Exception Left ventricular ejection fraction Echocardiography

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0010055
UMLS CUI [3]
C0441471
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0428772
UMLS CUI [4,3]
C0013516
current acute decompensated hf requiring therapy.
Description

Decompensated cardiac failure Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0581377
UMLS CUI [1,2]
C0332121
patients who require treatment with 2 or more of the following: an angiotensin converting enzyme inhibitor (acei), an angiotensin receptor blocker (arb) or a renin inhibitor
Description

Patient need for Angiotensin-Converting Enzyme Inhibitors | Patient need for Angiotensin II receptor antagonist | Patient need for Renin-inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0003015
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C0521942
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C3653375
alternative reason for shortness of breath such as: significant pulmonary disease or severe copd, hemoglobin (hgb) <10 g/dl, or body mass index (bmi) > 40 kg/m2.
Description

Dyspnea Etiology aspects | Lung disease | Severe chronic obstructive pulmonary disease | Hemoglobin measurement | Body mass index

Data type

boolean

Alias
UMLS CUI [1,1]
C0013404
UMLS CUI [1,2]
C0015127
UMLS CUI [2]
C0024115
UMLS CUI [3]
C0730607
UMLS CUI [4]
C0518015
UMLS CUI [5]
C1305855
systolic blood pressure (sbp) ≥ 180 mmhg at entry, or sbp >150 mmhg and <180 mmhg at entry unless the patient is receiving 3 or more antihypertensive drugs.
Description

Systolic Pressure | Exception Antihypertensive Agents Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003364
UMLS CUI [2,3]
C1265611
other protocol-defined inclusion/exclusion criteria may apply.
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563

Similar models

Eligibility Heart Failure With Preserved Ejection Fraction NCT01920711

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) ≥45% prior to study entry.
boolean
C0428772 (UMLS CUI [1])
Symptoms Heart failure | Requirement Diuretics Heart failure
Item
symptom(s) of heart failure (hf) and requiring treatment with diuretic(s) for hf ≥30 days prior to study entry
boolean
C1457887 (UMLS CUI [1,1])
C0018801 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0012798 (UMLS CUI [2,2])
C0018801 (UMLS CUI [2,3])
Symptoms Heart failure
Item
current symptom(s) of hf
boolean
C1457887 (UMLS CUI [1,1])
C0018801 (UMLS CUI [1,2])
Structural disorder of heart Echocardiography | Left atrial hypertrophy Echocardiography | Left Ventricular Hypertrophy Echocardiography
Item
structural heart disease (left atrial enlargement or left ventricular hypertrophy) documented by echocardiogram
boolean
C1290384 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
C0238705 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
C0149721 (UMLS CUI [3,1])
C0013516 (UMLS CUI [3,2])
Hospitalization Due to Heart Failure | NT-proBNP increased
Item
at least one of the following: a hf hospitalization within 9 months prior to study entry and/or an elevated nt-probnp.
boolean
C3898876 (UMLS CUI [1])
C3203735 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Left ventricular ejection fraction
Item
any prior measurement of lvef < 45%.
boolean
C0428772 (UMLS CUI [1])
Acute Coronary Syndrome | Myocardial Infarction | Cardiac Surgery procedures | Cardiovascular Surgical Procedures Major | Percutaneous Coronary Intervention Urgent
Item
acute coronary syndrome (including mi), cardiac surgery, other major cv surgery within 3 months , or urgent percutaneous coronary intervention (pci) within 30 days of entry.
boolean
C0948089 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0018821 (UMLS CUI [3])
C0038897 (UMLS CUI [4,1])
C0205164 (UMLS CUI [4,2])
C1532338 (UMLS CUI [5,1])
C0439609 (UMLS CUI [5,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Event | Exception Left ventricular ejection fraction Echocardiography
Item
patients who have had an mi, coronary artery bypass graft (cabg) or other event within the 6 months prior to entry unless an echo measurement performed after the event confirms a lvef ≥45%.
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0441471 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0428772 (UMLS CUI [4,2])
C0013516 (UMLS CUI [4,3])
Decompensated cardiac failure Treatment required for
Item
current acute decompensated hf requiring therapy.
boolean
C0581377 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Patient need for Angiotensin-Converting Enzyme Inhibitors | Patient need for Angiotensin II receptor antagonist | Patient need for Renin-inhibitors
Item
patients who require treatment with 2 or more of the following: an angiotensin converting enzyme inhibitor (acei), an angiotensin receptor blocker (arb) or a renin inhibitor
boolean
C0686904 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C0686904 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C3653375 (UMLS CUI [3,2])
Dyspnea Etiology aspects | Lung disease | Severe chronic obstructive pulmonary disease | Hemoglobin measurement | Body mass index
Item
alternative reason for shortness of breath such as: significant pulmonary disease or severe copd, hemoglobin (hgb) <10 g/dl, or body mass index (bmi) > 40 kg/m2.
boolean
C0013404 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0024115 (UMLS CUI [2])
C0730607 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C1305855 (UMLS CUI [5])
Systolic Pressure | Exception Antihypertensive Agents Quantity
Item
systolic blood pressure (sbp) ≥ 180 mmhg at entry, or sbp >150 mmhg and <180 mmhg at entry unless the patient is receiving 3 or more antihypertensive drugs.
boolean
C0871470 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003364 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial